Clinical implication of catheter ablation for atrial fibrillation in patients with cardiac amyloidosis - Reply.
Nishimura T, Ochi Y, Arima N, Sugiura K, Hirota T, Kubo T, Yamasaki N, Kitaoka H.
J Cardiol Cases. 2025. In press
2024年
Oral anticoagulation in patients with hypertrophic cardiomyopathy and non-valvular atrial fibrillation in Japan.
Kitaoka H, Carroll R, Eugene N, Teixeira BC, Matsuo Y, Kubo T.
ESC Heart Fail 12; 326-337, 2024.
Associations between electrocardiographic findings and echocardiographic profiles in patients with hypertrophic cardiomyopathy.
Matsuo T, Ochi Y, Kubo T, Baba Y, Miyagawa K, Noguchi T, Hirota T, Hamada T, Yamasaki N, Kitaoka H.
J Cardiol 83; 359-364, 2024.
alpha-L-iduronidase fused with humanized anti-human transferrin receptor antibody (lepunafusp alfa) for mucopolysaccharidosis type I: A phase 1/2 trial.
Harmatz P, Giugliani R, Martins AM, Hamazaki T, Kubo T, Kira R, Minami K, Ikeda T, Moriuchi H, Kawashima S, Takasao N, So S, Sonoda H, Hirato T, Tanizawa K, Schmidt M, Sato Y.
Mol Ther 32; 609-618, 2024.
Demographic Determinants Influencing the Adoption of Genetic Testing for Cardiovascular Diseases in Japan - Insights From a Large-Scale Online Survey.
Isa K, Suzuki T, Nomura S, Miyoshi T, Fujita K, Kubo T, Yoneoka D, Mizuno A
Circ Rep 6; 178-182, 2024
Prognostic impact of frailty based on a comprehensive frailty assessment in patients with heart failure.
Hamada T, Kubo T, Kawai K, Nakaoka Y, Yabe T, Furuno T, Yamada E, Kitaoka H; Kochi YOSACOI study.
ESC Heart Fail. 2024 Mar 28.doi: 10.1002/ehf2.14728.
Clinical features of quadricuspid aortic valve in middle-aged and elderly patients: Insights from a regional study.
Takiishi A, Baba Y, Ochi Y, Hotta M, Okazaki N, Yoshinaga Y, Miyamoto S, Hirakawa D, Kawaguchi J, Kubo T, Yamasaki N, Tokuhiro S, Kitaoka H.
Takotsubo Syndrome in Older Men: Clinical Characteristics Differ by Sex and Age.
Nishimura YK, Komatsu J, Sugane H, Hosoda H, Imai R, Nakaoka Y, Nishida K, Seki S, Kubo T, Kitaoka H, Kubokawa S, Kawai K, Hamashige N, Doi Y.
Circ Rep 6; 201-208, 2024.
Early Invasive Strategy for Octogenarians and Nonagenarians With Acute Myocardial Infarction.
Komatsu J, Nishimura YK, Sugane H, Hosoda H, Imai RI, Nakaoka Y, Nishida K, Mito S, Seki SI, Kubo T, Kitaoka H, Kubokawa SI, Kawai K, Hamashige N, Doi YL.:
Circ Rep 6; 263-271, 2024.
Effects of renin-angiotensin system inhibitor and beta-blocker use on mortality in older patients with heart failure with reduced ejection fraction in Japan.
Kawada K, Ishida T, Fukuda H, Hyohdoh Y, Kubo T, Hamada T, Baba Y, Hayashi T, Aizawa F, Yagi K, Izawa-Ishizawa Y, Niimura T, Abe S, Goda M, Kitaoka H, Ishizawa K.
Front Cardiovasc Med. 2024 May 31;11:1377228. doi: 10.3389/fcvm.2024.1377228. eCollection 2024.
Association of Multiple Nonhypertrophic Cardiomyopathy-Related Genetic Variants and Outcomes in Patients With Hypertrophic Cardiomyopathy.
Hiruma T, Inoue S, Dai Z, Nomura S, Kubo T, Sugiura K, Suzuki A, Kashimura T, Matsushima S, Yamada T, Tobita T, Katoh M, Ko T, Ito M, Ishida J, Amiya E, Hatano M, Takeda N, Takimoto E, Akazawa H, Morita H, Yamaguchi J, Inomata T, Tsutsui H, Kitaoka H, Aburatani H, Takeda N, Komuro I.
JACC Heart Fail 12; 2041-2052, 2024.
Relationship of Mild to Moderate Impairment of Left Ventricular Ejection Fraction With Fatal Ventricular Arrhythmic Events in Cardiac Sarcoidosis.
Akama Y, Fujimoto Y, Matsue Y, Maeda D, Yoshioka K, Dotare T, Sunayama T, Nabeta T, Naruse Y, Kitai T, Taniguchi T, Sato S, Tanaka H, Okumura T, Baba Y, Minamino T.
J Am Heart Assoc. 2024 Mar 19;13(6):e032047. doi: 10.1161/JAHA.123.032047. Epub 2024 Mar 8.
Clinical characteristics and prognosis of patients with isolated cardiac sarcoidosis: Insights from the ILLUMINATE-CS study.
Maeda D, Matsue Y, Dotare T, Sunayama T, Iso T, Yoshioka K, Nabeta T, Naruse Y, Kitai T, Taniguchi T, Tanaka H, Okumura T, Baba Y, Minamino T.
Prospective Multicenter Screening With High-Sensitivity Cardiac Troponin T for Wild-Type Transthyretin Cardiac Amyloidosis in Outpatient and Community-Based Settings.
Arima N, Ochi Y, Kubo T, Murakami Y, Nishino K, Yamamoto H, Satou K, Tamura S, Okawa M, Takata H, Shimizu Y, Baba Y, Yamasaki N, Kitaoka H.
Circ J. 2024; 89:24-30.
JCS/JCC/JSPCCS 2024 Guideline on Genetic Testing and Counseling in Cardiovascular Disease.
Imai Y, Kusano K, Aiba T, Ako J, Asano Y, Harada-Shiba M, Kataoka M, Kosho T, Kubo T, Matsumura T, Minamino T, Minatoya K, Morita H, Nishigaki M, Nomura S, Ogino H, Ohno S, Takamura M, Tanaka T, Tsujita K, Uchida T, Yamagishi H, Ebana Y, Fujita K, Ida K, Inoue S, Ito K, Kuramoto Y, Maeda J, Matsunaga K, Neki R, Sugiura K, Tada H, Tsuji A, Yamada T, Yamaguchi T, Yamamoto E, Kimura A, Kuwahara K, Maemura K, Minamino T, Morisaki H, Tokunaga K; Japanese Circulation Society, Japanese College of Cardiology, Japanese Society of Pediatric Cardiology and Cardiac Surgery Joint Working Group.
Circ J 88; 2022-2099, 2024.
Transthyretin amyloid cardiomyopathy: Literature review and red-flag symptom clusters for each cardiology specialty.
Izumiya Y, Kubo T, Endo J, Takashio S, Minamisawa M, Hamada J, Ishii T, Abe H, Konishi H, Tsujita K.
ESC Heart Fail 2024 Aug 21. doi: 10.1002/ehf2.15016. Online ahead of print.
Effects of renin-angiotensin system inhibitor and beta-blocker use on mortality in older patients with heart failure with reduced ejection fraction in Japan.
Kawada K, Ishida T, Fukuda H, Hyohdoh Y, Kubo T, Hamada T, Baba Y, Hayashi T, Aizawa F, Yagi K, Izawa-Ishizawa Y, Niimura T, Abe S, Goda M, Kitaoka H, Ishizawa K.
Front Cardiovasc Med. 2024 May 31;11:1377228. doi:10.3389/fcvm.2024.1377228. eCollection 2024.
Association Between Right Bundle Branch Block and Ventricular Arrhythmia in Patients With Cardiac Sarcoidosis.
Yamada Y, Sato K, Yamamoto M, Nabeta T, Naruse Y, Taniguchi T, Kitai T, Yoshioka K, Tanaka H, Okumura T, Baba Y, Fujimoto Y, Matsue Y, Komatsu Y, Nogami A, Ishizu T.
JACC Adv. 2024 Jul 12;3(8):101105.
doi: 10.1016/j.jacadv.2024.101105. eCollection 2024 Aug.
Cardiac sarcoidosis treated with nonsteroidal immunosuppressive therapy.
Suwa K, Naruse Y, Nabeta T, Kitai T, Taniguchi T, Yoshioka K, Tanaka H, Okumura T, Baba Y, Matsue Y, Maekawa Y.
Int J Cardiol Heart Vasc. 2024 Jul 23;53:101473.
doi: 10.1016/j.ijcha.2024.101473. eCollection 2024 Aug.
Prognostic role of high-sensitivity cardiac troponin T in patients with cardiac sarcoidosis: insights from ILLUMINATE-CS.
Baba Y, Kubo T, Nabeta T, Matsue Y, Kitai T, Naruse Y, Taniguchi T, Tanaka H, Okumura T, Yoshioka K, Kitaoka H.
ESC Heart Fail. 2024 Dec 27. doi: 10.1002/ehf2.15058.
Corticosteroid therapy and long-term outcomes in patients with cardiac sarcoidosis stratified by left ventricular ejection fraction.
Segawa T, Taniguchi T, Nabeta T, Naruse Y, Kitai T, Yoshioka K, Tanaka H, Okumura T, Baba Y, Matsue Y, Sakata Y.
ESC Heart Fail. 2024 Dec 27. doi: 10.1002/ehf2.15058.
Importance of fourth heart sound and preserved left atrial function in wild-type transthyretin amyloidosis.
Ochi Y, Yamasaki N, Kubo T, Baba Y, Miyagawa K, Noguchi T, Hirota T, Hamada T, Kitaoka H.
ESC Heart Fail. 2024 ;11:4000-4008.
Trends in clinical practice for wild-type transthyretin amyloid cardiomyopathy from Kochi amyloidosis cohort: Impact of a new guideline and diagnosis and treatment strategy in Japan.
Ochi Y, Kubo T, Baba Y, Miyagawa K, Noguchi T, Hirota T, Yamasaki N, Kitaoka H.
J Cardiol. 2024 :S0914-5087(24)00224-7.
A case of cardiac amyloidosis presenting stiff left atrial syndrome with severe calcification after first AF ablation.
Nishimura T, Ochi Y, Arima N, Sugiura K, Hirota T, Kubo T, Yamasaki N, Kitaoka H.
J Cardiol Cases. 2024 ;31: 20-23.
Characteristics and outcomes of patients with stent implantation for coronary artery lesions caused by Kawasaki disease - insights from second-generation stent implantation.
Natsuko Ishi, Etsuko Tsuda
Cardiol Youn. 2024 Oct 30:1-7.
2023年
Frailty interferes with the guideline-directed medical therapy in heart failure patients with reduced ejection fraction.
Hamada T, Kubo T, Kawai K, Nakaoka Y, Yabe T, Furuno T, Yamada E, Kitaoka H; Kochi YOSACOI study.
ESC Heart Fail 10; 223-233, 2023.
Current state of knowledge and information sharing among home healthcare professionals involved in heart failure management.
Shimomoto R, Kubo T, Yamanaka F, Tsuchihashi-Makaya M, Suganuma N, Kitaoka H.
J Cardiol 81; 292-296, 2023.
Estimating the prevalence, clinical characteristics, and treatment patterns of hypertrophic cardiomyopathy in Japan: A nationwide medical claims database study.
Terasaka N, Spanopoulos D, Miyagoshi H, Kubo T, Kitaoka H.
J Cardiol 81; 316-322, 2023.
External Validation of the Japanese Clinical Score for Mortality Prediction in Patients With Acute Heart Failure.
High-sensitivity Cardiac Troponin T is a Useful Biomarker for Predicting the Prognosis of Patients with Systemic Sarcoidosis Regardless of Cardiac Involvement.
Baba Y, Kubo T, Ochi Y, Hirota T, Yamasaki N, Ohnishi H, Kubota T, Yokoyama A, Kitaoka H.
Intern Med 62; 3097-3105, 2023.
JCS 2023 Guideline on the Diagnosis and Treatment of Myocarditis.
Nagai T, Inomata T, Kohno T, Sato T, Tada A, Kubo T, Nakamura K, Oyama-Manabe N, Ikeda Y, Fujino T, Asaumi Y, Okumura T, Yano T, Tajiri K, Matsuura H, Baba Y, Sunami H, Tsujinaga S, Ota Y, Ohta-Ogo K, Ishikawa Y, Matama H, Nagano N, Sato K, Yasuda K, Sakata Y, Kuwahara K, Minamino T, Ono M, Anzai T; Japanese Circulation Society Joint Working Group.
Circ J 87; 674-754, 2023.
Genetic Testing for Cardiomyopathy in Japan 2022: Current Status and Issues of Precision Medicine.
Kubo T, Kitaoka H
J Card Fail 29: 805-814, 2023.（IF 6.7）
Transient decrease in the depth of the negative T wave in apical hypertrophic cardiomyopathy is a sign of left anterior descending artery stenosis: a case series.
Arima N, Ochi Y, Takahashi M, Moriki T, Noguchi T, Kubo T, Yamasaki N, Kitaoka H.
Eur Heart J Case Rep 7(1):ytad034, 2023.
Mitral Valve Repair with Papillary Muscle Repositioning for Functional Mitral Regurgitation (Type IIIb) with Metal Allergies: A Case Report. European Heart Journal - Case Reports.
Mitsuishi A, Miura Y, Kubo T.
Eur Heart J Case Rep 7; ytad283, 2023.
Characteristics and incidence of cardiac events across spectrum of age in cardiac sarcoidosis.
Nabeta T, Matsumoto S, Ishii S, Eda Y, Yazaki M, Fujita T, Iida Y, Ikeda Y, Kitai T, Naruse Y, Taniguchi T, Yoshioka K, Tanaka H, Okumura T, Baba Y, Matsue Y, Ako J.
Int J Cardiol Heart Vasc. 2023 Dec 8;50:101321. doi: 10.1016/j.ijcha.2023.101321. eCollection 2024 Feb.
Prevalence and prognostic value of atrial fibrillation in patients with cardiac sarcoidosis.
Fujimoto Y, Matsue Y, Maeda D, Dotare T, Sunayama T, Iso T, Nakamura Y, Singh YS, Akama Y, Yoshioka K, Kitai T, Naruse Y, Taniguchi T, Tanaka H, Okumura T, Baba Y, Nabeta T, Minamino T.
The role of ferroptosis in cell-to-cell propagation of cell death initiated from focal injury in cardiomyocytes.
Kawasaki NK, Suhara T, Komai K, Shimada BK, Yorichika N, Kobayashi M, Baba Y, Higa JK, Matsui T.
Life Sci. 2023 Nov 1;332:122113. doi: 10.1016/j.lfs.2023.122113. Epub 2023 Sep 20.
Prognostic Implication of the Resolution of Myocardial FDG Uptake in Patients With Cardiac Sarcoidosis.
Okabe T, Nabeta T, Naruse Y, Taniguchi T, Kitai T, Yoshioka K, Tanaka H, Okumura T, Baba Y, Matsue Y.
JACC Asia. 2023 Jun 27;3(4):683-685. doi: 10.1016/j.jacasi.2023.04.007. eCollection 2023 Aug.
Sex differences in clinical characteristics and prognosis of patients with cardiac sarcoidosis.
Iso T, Maeda D, Matsue Y, Dotare T, Sunayama T, Yoshioka K, Nabeta T, Naruse Y, Kitai T, Taniguchi T, Tanaka H, Okumura T, Baba Y, Minamino T.
Heart. 2023 Aug 24;109(18):1387-1393. doi: 10.1136/heartjnl-2022-322243.
JCS 2023 Guideline on the Diagnosis and Treatment of Myocarditis.
Nagai T, Inomata T, Kohno T, Sato T, Tada A, Kubo T, Nakamura K, Oyama-Manabe N, Ikeda Y, Fujino T, Asaumi Y, Okumura T, Yano T, Tajiri K, Matsuura H, Baba Y, Sunami H, Tsujinaga S, Ota Y, Ohta-Ogo K, Ishikawa Y, Matama H, Nagano N, Sato K, Yasuda K, Sakata Y, Kuwahara K, Minamino T, Ono M, Anzai T; Japanese Circulation Society Joint Working Group.
Circ J. 2023 Apr 25;87(5):674-754. doi: 10.1253/circj.CJ-22-0696. Epub 2023 Mar 31.
2022年
External Validation of the Japanese Clinical Score for Mortality Prediction in Patients With Acute Heart Failure.
Circ J. 2022 Dec 28. doi: 10.1253/circj.CJ-22-0652.
The Prognostic Value of B-Type Natriuretic Peptide in Patients With Cardiac Sarcoidosis Without Heart Failure: Insights From ILLUMINATE-CS.
Miyakuni S, Maeda D, Matsue Y, Yoshioka K, Dotare T, Sunayama T, Nabeta T, Naruse Y, Kitai T, Taniguchi T, Tanaka H, Okumura T, Baba Y, Matsumura A, Minamino T.
J Am Heart Assoc. 2022 Dec 20;11(24):e025803.
Comparisons between biopsy-proven versus clinically diagnosed cardiac sarcoidosis.
Kitai T, Nabeta T, Naruse Y, Taniguchi T, Yoshioka K, Miyakoshi C, Kurashima S, Miyoshi Y, Tanaka H, Okumura T, Baba Y, Furukawa Y, Matsue Y, Izumi C.
Heart. 2022 Nov 10;108(23):1887-1894.
Clinical Management and Outcomes of Patients With Portopulmonary Hypertension Enrolled in the Japanese Multicenter Registry.
Tamura Y, Tamura Y, Taniguchi Y, Tsujino I, Inami T, Matsubara H, Shigeta A, Sugiyama Y, Adachi S, Abe K, Baba Y, Hatano M, Ikeda S, Kusunose K, Sugimura K, Usui S, Takeishi Y, Dohi K, Hasegawa-Tamba S, Horimoto K, Kikuchi N, Kumamaru H, Tatsumi K; Japan Pulmonary Hypertension Registry Network.
Circ Rep. 2022 Oct 8;4(11):542-549.
Risk stratification of patients with cardiac sarcoidosis: the ILLUMINATE-CS registry.
Nabeta T, Kitai T, Naruse Y, Taniguchi T, Yoshioka K, Tanaka H, Okumura T, Sato S, Baba Y, Kida K, Tamaki Y, Matsumoto S, Matsue Y.
Eur Heart J. 2022 Sep 21;43(36):3450-3459.
Acute Left Circumflex Coronary Artery Occlusion - Diagnostic Problems of Initial
Komatsu J, Nishimura YK, Sugane H, Hosoda H, Imai RI, Nakaoka Y, Nishida K, Seki SI, Kubo T, Yamasaki N, Kitaoka H, Kubokawa SI, Kawai K, Hamashige N, Doi Y.
Incidence and Clinical Characteristics of Takotsubo Syndrome in Patients with Subarachnoid Hemorrhage.
Fujita T, Nakaoka Y, Hayashi S, Imai RI, Nishida K, Seki SI, Kubo T, Yamasaki N, Kitaoka H, Kubokawa SI, Kawai K, Hamashige N, Doi Y.
Int Heart J 63; 517-523, 2022.
The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy.
Norrish G, Topriceanu C, Qu C, Field E, Walsh H, Ziółkowska L, Olivotto I, Passantino S, Favilli S, Anastasakis A, Vlagkouli V, Weintraub R, King I, Biagini E, Ragni L, Prendiville T, Duignan S, McLeod K, Ilina M, Fernández A, Bökenkamp R, Baban A, Drago F, Kubuš P, Daubeney PEF, Chivers S, Sarquella-Brugada G, Cesar S, Marrone C, Medrano C, Alvarez Garcia-Roves R, Uzun O, Gran F, Castro FJ, Gimeno JR, Barriales-Villa R, Rueda F, Adwani S, Searle J, Bharucha T, Siles A, Usano A, Rasmussen TB, Jones CB, Kubo T, Mogensen J, Reinhardt Z, Cervi E, Elliott PM, Omar RZ, Kaski JP.
Eur J Prev Cardiol 29; 645-653, 2022.
Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator.
Protonotarios A, Bariani R, Cappelletto C, Pavlou M, García-García A, Cipriani A, Protonotarios I, Rivas A, Wittenberg R, Graziosi M, Xylouri Z, Larrañaga-Moreira JM, de Luca A, Celeghin R, Pilichou K, Bakalakos A, Lopes LR, Savvatis K, Stolfo D, Dal Ferro M, Merlo M, Basso C, Freire JL, Rodriguez-Palomares JF, Kubo T, Ripoll-Vera T, Barriales-Villa R, Antoniades L, Mogensen J, Garcia-Pavia P, Wahbi K, Biagini E, Anastasakis A, Tsatsopoulou A, Zorio E, Gimeno JR, Garcia-Pinilla JM, Syrris P, Sinagra G, Bauce B, Elliott PM.
Eur Heart J 43; 3053-3067, 2022.
Assisted living and medication adherence in super-aged patients with heart failure in the Japanese population.
Kawada K, Kubo T, Ishida T, Jobu K, Morisawa S, Hamada T, Baba Y, Kawai K, Nakaoka Y, Yabe T, Furuno T, Yamada E, Fukuda H, Ohta T, Hayashi T, Kitaoka H, Miyamura M.
J Cardiovasc Pharmacol 79; 467-471, 2022.
A Drifting Dislodged Leadless Pacemaker in the Bilateral Pulmonary Arteries.
Sugiura K, Baba Y, Hirota T, Kubo T, Kitaoka H.
JACC Case Rep 4: 844-846, 2022.
Very long-term prognosis in patients with hypertrophic cardiomyopathy: a longitudinal study with a period of 20 years.
Sugiura K, Kubo T, Ochi Y, Miyagawa K, Baba Y, Noguchi T, Hirota T, Yamasaki N, Doi YL,Kitaoka H.
ESC Heart Fail 9; 2618-2625, 2022.
Clinical Features of Heart Failure in Patients With Hypertrophic Cardiomyopathy in a Regional Japanese Cohort - Results From the Kochi RYOMA Study.
Miyamoto Y, Kubo T, Ochi Y, Baba Y, Hirota T, Yamasaki N, Kawai K, Yamamoto K, Kondo F, Bando K, Yamada E, Furuno T, Yabe T, Doi YL, Kitaoka H.
Circ J 86; 1939-1940, 2022.
Early Experience of Tafamidis Treatment in Japanese Patients With Wild-Type Transthyretin Cardiac Amyloidosis From the Kochi Amyloidosis Cohort.
Ochi Y, Kubo T, Baba Y, Sugiura K, Miyagawa K, Noguchi T, Hirota T, Hamada T, Yamasaki N, Kitaoka H.
Circ J 86; 1121-1128, 2022.
Clinical characteristics and frailty status in heart failure with preserved vs. reduced ejection fraction.
Hamada T, Kubo T, Kawai K, Nakaoka Y, Yabe T, Furuno T, Yamada E, Kitaoka H; Kochi YOSACOI study.
ESC Heart Fail 9; 1853-1863, 2022.
A retrospective investigation to establish new screening approach for the detection of patients at high risk of Fabry disease in male left ventricular hypertrophy patients.
Kubo T, Amano M, Takashio S, Okumura T, Yamamoto S, Nabeta T, Oikawa M, Kurisu S, Ochi Y, Sugiura K, Baba Y, Kuroiwa H, Hirota T, Yamasaki N, Ishii S, Nochioka K, Takeishi Y, Yasuda S, Tsujita K, Izumi C, Kitaoka H.
J Cardiol 80; 325-331, 2022.
Relationship Between Maximal Left Ventricular Wall Thickness and Sudden Cardiac Death in Childhood Onset Hypertrophic Cardiomyopathy.
Norrish G, Ding T, Field E, Cervi E, Ziółkowska L, Olivotto I, Khraiche D, Limongelli G, Anastasakis A, Weintraub R, Biagini E, Ragni L, Prendiville T, Duignan S, McLeod K, Ilina M, Fernández A, Marrone C, Bökenkamp R, Baban A, Kubus P, Daubeney PEF, Sarquella-Brugada G, Cesar S, Klaassen S, Ojala TH, Bhole V, Medrano C, Uzun O, Brown E, Gran F, Sinagra G, Castro FJ, Stuart G, Vignati G, Yamazawa H, Barriales-Villa R, Garcia-Guereta L, Adwani S, Linter K, Bharucha T, Garcia-Pavia P, Siles A, Rasmussen TB, Calcagnino M, Jones CB, De Wilde H, Kubo T, Felice T, Popoiu A, Mogensen J, Mathur S, Centeno F, Reinhardt Z, Schouvey S, O'Mahony C, Omar RZ, Elliott PM, Kaski JP.
Clinical characteristics and frailty status in heart failure with preserved vs. reduced ejection fraction.
Hamada T, Kubo T, Kawai K, Nakaoka Y, Yabe T, Furuno T, Yamada E, Kitaoka H; Kochi YOSACOI study.
ESC Heart Fail. 2022 Mar 30.
99m Technetium-pyrophosphate scintigraphy: a practical guide for early diagnosis of transthyretin amyloid cardiomyopathy.
Tahara N, Lairez O, Endo J, Okada A, Ueda M, Ishii T, Kitano Y, Lee HE, Russo E, Kubo T
ESC Heart Fail 9; 251-262, 2022.
2021年
Assisted Living and Medication Adherence in Super-Aged Patients With Heart Failure in the Japanese population.
Kawada K, Kubo T, Ishida T, Jobu K, Morisawa S, Hamada T, Baba Y, Kawai K, Nakaoka Y, Yabe T, Furuno T, Yamada E, Fukuda H, Ohta T, Hayashi T, Kitaoka H, Miyamura M.
J Cardiovasc Pharmacol. 2021 Dec 27.
Association between acute coronary syndrome onset risk and climate change.
Aoyagi T, Chiba Y, Kitaoka H.
Arch Environ Occup Health. 2021 Dec 15:1-10.
Early cardiac rehabilitation for acute decompensated heart failure safely improves physical function (PEARL study): a randomized controlled trial.
Nakaya Y, Akamatsu M, Ogimoto A, Kitaoka H.
Eur J Phys Rehabil Med. 2021 Dec;57(6):985-993.
Clinical significance of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy.
Kubo T, Baba Y, Ochi Y, Hirota T, Yamasaki N, Kawai K, Yamamoto K, Kondo F, Bando K, Yamada E, Furuno T, Yabe T, Doi YL, Kitaoka H.
ESC Heart Fail. 2021 Dec;8(6):5022-5030.
Diagnostic and Therapeutic Strategy for Female Patients With Cardiac Amyloidosis - Reply.
Ochi Y, Kubo T, Baba Y, Yamasaki N, Kitaoka H.
Circ Rep. 2021 Nov 11;3(12):749-750.
The High Road or the Low Road? A Question Regarding Whether to Use Upper or Lower Pulmonary Veins in Measuring Pulmonary Vein Flow.
Baba Y, Kubo T, Kitaoka H.
J Am Soc Echocardiogr. 2021 Oct;34(10):1116-1117.
Progressive deterioration of frailty is associated with poor outcomes in patients with transthyretin cardiac amyloidosis.
Takahashi M, Okamoto N, Nishida K, Nakaoka Y, Imai RI, Seki SI, Kubo T, Yamasaki N, Kitaoka H, Kubokawa SI, Kawai K, Hamashige N, Doi Y.
Geriatr Gerontol Int. 2021 Oct;21(10):967-969.
JCS/JHFS 2018 Guideline on the Diagnosis and Treatment of Cardiomyopathies.
Kitaoka H, Tsutsui H, Kubo T, Ide T, Chikamori T, Fukuda K, Fujino N, Higo T, Isobe M, Kamiya C, Kato S, Kihara Y, Kinugawa K, Kinugawa S, Kogaki S, Komuro I, Hagiwara N, Ono M, Maekawa Y, Makita S, Matsui Y, Matsushima S, Sakata Y, Sawa Y, Shimizu W, Teraoka K, Tsuchihashi-Makaya M, Ishibashi-Ueda H, Watanabe M, Yoshimura M, Fukusima A, Hida S, Hikoso S, Imamura T, Ishida H, Kawai M, Kitagawa T, Kohno T, Kurisu S, Nagata Y, Nakamura M, Morita H, Takano H, Shiga T, Takei Y, Yuasa S, Yamamoto T, Watanabe T, Akasaka T, Doi Y, Kimura T, Kitakaze M, Kosuge M, Takayama M, Tomoike H
Japanese Circulation Society Joint Working Group.Circ J. 2021 Aug 25;85(9):1590-1689.
Frailty in patients with acute decompensated heart failure in a super-aged regional Japanese cohort.
Hamada T, Kubo T, Kawai K, Nakaoka Y, Yabe T, Furuno T, Yamada E, Kitaoka H; Kochi YOSACOI study.
ESC Heart Fail. 2021 Aug;8(4):2876-2888.
Wild-Type Transthyretin Amyloidosis in Female Patients - Consideration of Sex Differences.
Ochi Y, Kubo T, Baba Y, Sugiura K, Ueda M, Miyagawa K, Noguchi T, Hirota T, Hamada T, Yamasaki N, Kitaoka H.
Circ Rep. 2021 Jun 29;3(8):465-471
What is low cardiac output syndrome? A report of two cases
Baba Y, Kubo T, Ochi Y, Noguchi T, Yamasaki N, Kitaoka H
Crit Care Shock (2021) 24:135-142
Tenosynovial and Cardiac Transthyretin Amyloidosis in Japanese Patients Undergoing Carpal Tunnel Release.
Sugiura K, Kozuki H, Ueba H, Kubo T, Ochi Y, Baba Y, Miyagawa K, Noguchi T, Hirota T, Yamasaki N, Wada N, Nakashima J, Murakami I, Ikeuchi M, Kitaoka H.
Circ Rep. 2021 May 27;3(6):338-344.
Association between self-reported night sleep duration and cognitive function among older adults with intact global cognition.
Kondo R, Miyano I, Lee S, Shimada H, Kitaoka H.
Int J Geriatr Psychiatry. 2021 May;36(5):766-774.
A Case Report of Asymmetry of Systolic Anterior Motion of the Mitral Valve, a Not Widely Well-Known but Practically Important Echocardiographic Presentation in Hypertrophic Cardiomyopathy.
Ochi Y, Kubo T, Baba Y, Ueda M, Hirota T, Yamasaki N, Kitaoka H.
CASE (Phila). 2021 Apr 8;5(3):160-165.
Added value of anxiolytic benzodiazepines in predictive models on severe delirium in patients with acute decompensated heart failure: A retrospective analysis.
Kawada K, Fukuda H, Kubo T, Ohta T, Ishida T, Morisawa S, Kawazoe T, Okamoto M, Fujita H, Jobu K, Morita Y, Ueba T, Kitaoka H, Miyamura M.
PLoS One. 2021 Apr 22;16(4):e0250372.
A Validation Study of the Mayo Clinic Phenotype-Based Genetic Test Prediction Score for Japanese Patients With Hypertrophic Cardiomyopathy.
Moriki T, Kubo T, Sugiura K, Ochi Y, Baba Y, Hirota T, Yamasaki N, Kimura A, Doi YL, Kitaoka H.
Circ J. 2021 Apr 23;85(5):669-674.
Validation of the Kumamoto criteria for prediction of 99m technetium pyrophosphate scintigraphy positivity as a strategy for diagnosis of transthyretin cardiac amyloidosis: A retrospective cohort study in Kochi.
Ochi Y, Kubo T, Baba Y, Ueda M, Miyagawa K, Noguchi T, Hirota T, Yamasaki N, Kitaoka H
J Cardiol 77; 124-130, 2021
What we believed to be a right upper pulmonary vein by transthoracic echocardiography is actually a right lower pulmonary vein.
Baba Y, Ochi Y, Hirota T, Arima N, Sugiura K, Kawaguchi J, Hirakawa D, Kubo T, Yamasaki N, Kitaoka H:
Echocardiography 38; 427-434, 2021.
The dawn of precision medicine in cardiomyopathies Advance preparations of ethnicity-specific database
Kubo T, Morita H
Circ J 85; 1479-1480, 2021.
The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy.
Norrish G, Topriceanu C, Qu C, Field E, Walsh H, Ziółkowska L, Olivotto I, Passantino S, Favilli S, Anastasakis A, Vlagkouli V, Weintraub R, King I, Biagini E, Ragni L, Prendiville T, Duignan S, McLeod K, Ilina M, Fernández A, Bökenkamp R, Baban A, Drago F, Kubuš P, Daubeney PEF, Chivers S, Sarquella-Brugada G, Cesar S, Marrone C, Medrano C, Alvarez Garcia-Roves R, Uzun O, Gran F, Castro FJ, Gimeno JR, Barriales-Villa R, Rueda F, Adwani S, Searle J, Bharucha T, Siles A, Usano A, Rasmussen TB, Jones CB, Kubo T, Mogensen J, Reinhardt Z, Cervi E, Elliott PM, Omar RZ, Kaski JP
mTOR-mediated calcium transients affect cardiac function in ex vivo ischemia-reperfusion injury.
Shimada BK, Yorichika N, Higa JK, Baba Y, Kobayashi M, Aoyagi T, Suhara T, Matsui T.
Physiol Rep. 2021 Mar;9(6):e14807
2020年
Cardiac manifestations and effects of enzyme replacement therapy for over 10 years in adults with the attenuated form of mucopolysaccharidosis type I.
Sugiura K, Kubo T, Ochi Y, Baba Y, Hirota T, Yamasaki N, Kitaoka H.
Mol Genet Metab Rep. 2020 Oct 20;25:100662.
Elevation of high-sensitivity cardiac troponin T and left ventricular remodelling in hypertrophic cardiomyopathy.
Kubo T, Ochi Y, Baba Y, Sugiura K, Takahashi A, Hirota T, Yamanaka S, Yamasaki N, Doi YL, Kitaoka H.
ESC Heart Fail. 2020 Oct 12;7(6):3593-600.
The diaphragm affects echocardiographic measurement of inferior vena cava diameter to predict right atrial pressure.
Baba Y, Kawaguchi J, Ochi Y, Hirakawa D, Oryu T, Noguchi T, Hirota T, Kubo T, Yamasaki N, Kitaoka H.
J Med Ultrason (2001). 2020 Oct;47(4):565-573.
Lifelong Clinical Impact of the Presence of Sarcomere Gene Mutation in Japanese Patients With Hypertrophic Cardiomyopathy.
Nakashima Y, Kubo T, Sugiura K, Ochi Y, Takahashi A, Baba Y, Hirota T, Yamasaki N, Kimura A, Doi YL, Kitaoka H.
Circ J. 2020 Sep 25;84(10):1846-1853.
Sudden Cardiac Death-Relevant Events of Hypertrophic Cardiomyopathy in a Regional Japanese Cohort - Results From the Kochi RYOMA Study.
Kubo T, Baba Y, Ochi Y, Takahashi A, Hirota T, Yamasaki N, Hamashige N, Yamamoto K, Kondo F, Bando K, Yamada E, Furuno T, Yabe T, Doi YL, Kitaoka H.
Circ Rep. 2020 Jul 2;2(8):433-439.
Preoperative Clinical Features and High Pulmonary Wedge Pressure with a Discordant Pattern as Prognostic Factor in Hemodialysis Patients with Severe Aortic Valve Stenosis.
Ueda M, Kubo T, Ochi Y, Takahashi A, Miyagawa K, Baba Y, Noguchi T, Hirota T, Yamasaki N, Yamamoto M, Nishimori H, Sasaguri S, Orihashi K, Kitaoka H.
Int Heart J. 2020 Jul 30;61(4):720-726.
Hypertrophic Cardiomyopathy - A Heterogeneous and Lifelong Disease in the Real World.
Kitaoka H, Kubo T, Doi YL.
Circ J. 2020 Jul 22;84(8):1218-1226.
Effects of Switching from Treatment with Amlodipine and Atorvastatin Using Two Pills to an Equal Dose of Single-Pill Therapy in Japanese Outpatients.
Kawada Y, Kubo T, Baba Y, Hirota T, Tanioka K, Yamasaki N, Kitaoka H.
Acta Med Okayama. 2020 Apr;74(2):103-108.
Prediction of Medium-Term Mortality in Japanese Patients With Wild-Type Transthyretin Amyloidosis.
Ochi Y, Kubo T, Baba Y, Nakashima Y, Ueda M, Takahashi A, Miyagawa K, Noguchi T, Hirota T, Yamasaki N, Kitaoka H.
Circ Rep. 2020 Apr 29;2(6):314-321.
Beneficial Effect of Pimobendan for Severe Heart Failure Due to Transthyretin Cardiac Amyloidosis.
Okamoto N, Kubo T, Nakashima Y, Ochi Y, Takahashi A, Baba Y, Hirota T, Yamasaki N, Kitaoka H.
Intern Med. 2020 Feb 1;59(3):339-343.
Integrated diagnostic approach to wild-type transthyretin cardiac amyloidosis with the use of high-sensitivity cardiac troponin T measurement and 99mTc-pyrophosphate scintigraphy.
Ochi Y, Kubo T, Nakashima Y, Baba Y, Hirota T, Yamasaki N, Yamashita T, Ueda M, Ando Y, Kitaoka H.
J Cardiol. 2020 Jan;75(1):12-19.
和文論文
2024年
肥大型心筋症
久保 亨
最新の臨床WEB（WEB掲載）南江堂（2024.4.12）
循環器診療における遺伝学的検査の使い方
久保 亨
循環器疾患に対する遺伝子診断と治療Up to dat Heart View 5: 49-53頁 メジカルビュー社（2024.05）
'Color Doppler stripes' make it difficult to diagnose the severity of valvular heart diseases: a report of two cases.
Baba Y, Ochi Y, Kawaguchi J, Takiishi A, Hirakawa D, Kubo T, Yamasaki N, Kitaoka H.
Cardiovasc Ultrasound. 2024 Oct 7;22(1):12. doi: 10.1186/s12947-024-00331-1.
Who Moved the Left Ventricular Hypertrophy? Dynamic Changes Due to Fluctuation in Volume Overload.
Kawaguchi J, Kubo T, Ochi Y, Baba Y, Yamasaki N, Miura Y, Kawazoe K, Kitaoka H.
Circ J 88; 1345. 2024.
2023年
Where Is the Left Atrial Appendage Wall? Caution during Transesophageal Echocardiography.
Baba Y, Ochi Y, Kawaguchi J, Takiishi A, Hirota T, Kubo T, Yamasaki N, Kitaoka H.
CASE (Phila). 2023 Jun 12;7(8):338-342.doi: 10.1016/j.case.2023.04.008. eCollection 2023 Aug.
Left Atrial Appendage Closure with the Watchman FLX System in a Patient with Hypertrophic Cardiomyopathy on Dialysis for End-stage Renal Failure
Takashi Funaki, Mike Saji, Mai Terada, Itaru Takamisawa, Mamoru Nanasato, Takehiko Nagao, Takanori Ikeda, Mitsuaki Isobe.
Intern Med. 2024 Feb 1;63(3):399-402. DOI: 10.2169/internalmedicine.1778-23
2021年
A case reprt of asymmetry of systolic anterior motion of the mitral vlave, a not widely well-known but practically iportant echocardiographoic presentaton in hypertrophic cardiomyopathy.
Ochi Y, Kubo T, Baba Y, Ueda M, Hirota T, Yamasaki N, Kitaoka H.
CASE (Phila) 5: 160-165, 2021. (IF 5.251)
学会発表
2024年
Insights into atrial fibrillation and atrial function in patients with cardiac hypertrophy.
久保 亨
第88回日本循環器学会学術集会
Fabry disease and its cardiac involvement
久保 亨
第88回日本循環器学会学術集会
心筋症の遺伝医療：ATTRvアミロイドーシスを中心に
久保 亨
第11回日本アミロイドーシス学会学術集会
遺伝性循環器疾患のマネジメント
久保 亨
日本心臓病学会第72回学術集会
Clinical significance and practice of genetic diagnosis in hypertrophic cardiomyopathy
久保 亨
第60回日本小児循環器学会学術集会
HCMの遺伝学的検査をどのように臨床に活かすか
久保 亨
日本心臓病学会第72回学術集会
HCMの薬物治療の現在地と未来
久保 亨
日本心臓病学会第72回学術集会
心アミロイドーシスの診断
久保 亨
日本心臓病学会第72回学術集会
PhenotypeとGenotypeを意識した次世代の心筋症臨床
久保 亨
第28回日本心不全学会学術集会
Modes of Death in Patients with Heart Failure according to Walking Ability and Left Ventricular Ejection Fraction
Hamada T, Kubo T, Kawai K, Nakaoka Y, Yabe T, Furuno T, Yamada E, Kawada Y, Yamasaki N, Takabayashi K, Kitaoka H
第88回日本循環器学会学術集会
4D strainにて “真” のストレインにせまる -2D strainは虚像か？-
馬場 裕一
第35回日本心エコー図学会
四国の絆を心エコー図で結ぶ ～『高知家』の取り組み～
馬場 裕一
第35回日本心エコー図学会
なぜ心不全患者において鉄剤の有効性は限られているのか ～フェロトーシスを含めた基礎研究から考える～
馬場 裕一、松井 隆、北岡 裕章
第28回日本心不全学会学術集会
Prospective multi-center screening with high-sensitivity cardiac troponin T measurement for wild-type transthyretin cardiac amyloidosis in outpatient and community-based settings
The prognostic impact of cardio-renal anaemia syndrome in Japanese acute decompensated heart failure patients stratified by left ventricular ejection fraction
Moriki T, Hamada T, Kubo T, Takabayashi K, Kawai K, Nakaoka Y, Yabe T, Furuno T, Yamada E, Kitaoka H
European Society of Cardiology Congress, Amsterdam, 2023
Coronary ostial patch-angioplasty, a novel surgical technique using an external iliac artery for 3 young female patients with Takayasu arteritis
舟木 孝志
第87回 日本循環器学会学術集会
Mid-term outcome after transcatheter aortic valve replacement in patients with dementia: an insight from the LAPLACE-TAVI registry
舟木 孝志
第87回 日本循環器学会学術集会
Left atrial appendage closure with the Watchman FLX system in a patient with hypertrophic cardiomyopathy on dialysis for end-stage renal failure
舟木 孝志
PCR Tokyo Valves 2023
血管内視鏡にて左心耳閉鎖デバイスの内皮化を評価した1例
舟木 孝志
第16回TRANS CATHETER IMAGING FORUM
Intra-annular SEV がpop-outした1例: 至適な深さはどこにあるか
舟木 孝志
ストラクチャークラブ・ジャパン ライブデモンストレーション 2023
10年後のストラクチャーインターベンションを話そう
舟木 孝志
ストラクチャークラブ・ジャパン ライブデモンストレーション 2023
若手インタラクティブセッション：新時代はこの未来だーガイドライン改定は現場をどう変えたか？—
舟木 孝志
第31回日本心血管インターベンション治療学会学術集会
短腸症候群に対するテデュグルチド治療により心不全発症をきたした１例
吉本 公美
第123回日本循環器学会四国地方会
2022年
超高齢者(oldest-old)入院患者における リスクスコアを加味した抗血栓療法の考察
宮川 和也
第64回日本老年医学会学術集会
Prevalence and clinical impact of cardiorenal anemia syndrome in older patients with acute heart failure.
濵田 知幸
第26回日本心不全学会学術集会
高齢急性心不全患者におけるフレイル重積の退院1年以内の予後への影響
濵田 知幸
第64回日本老年医学会学術集会
Prognostic Impact of Frailty Status Based on the Kihon Checklist in Patients With Acute Decompensated Heart Failure
濵田 知幸
第86回日本循環器学会学術集会
Additional Prognostic Value of Frailty Assessment to the Get With the Guideline-Heart Failure Risk Score in Patients With Acute Decompensated Heart Failure
濵田 知幸
第86回日本循環器学会学術集会
Hydrophilic polymer emboli in patients with critical limb ischemia: a review of four cases leading to critical outcomes
宮本 雄也
第30回日本心血管インターベンション治療学会
What are the Characteristics of Lesions with Target Lesion Failure at Follow-up Coronary Angiography after Percutaneous Coronary Intervention?
Drug treatment for obstructive hypertrophic cardiomyopathy
久保亨, 杉浦健太. 山崎直仁,北岡裕章
第86回日本循環器学会学術集会
Prognostic Impact of Frailty Status Based on the Kihon Checklist in Patients With Acute Decompensated Heart Failure
濵田知幸,久保亨,中岡洋子,川井和哉,矢部敏和,桑原昌則,古野貴志,山田英介,山崎直仁,北岡裕章
第86回日本循環器学会学術集会
Additional Prognostic Value of Frailty Assessment to the Get With the Guideline-Heart Failure Risk Score in Patients With Acute Decompensated Heart Failure
濵田知幸,久保亨,中岡洋子,川井和哉,矢部敏和,桑原昌則,古野貴志,山田英介,山崎直仁,北岡裕章
第86回日本循環器学会学術集会
Induction of Autoimmune Myocarditis by CTLs Specific for Cardiac Myosin Heavy Chain-Alpha
